A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.

2 million individuals in the US live with type 1 diabetes and a rising number of type 2 patients require basal-bolus insulin therapy. Credit: Halfpoint via Shutterstock. The integration of Abbott’s ...

Carmat requires €3.5m “urgently” and around €35m over the next 12 months to continue operations. Image credit: ArtemisDiana via Shutterstock. France-based Carmat has filed for insolvency and requested ...

In the trial, patients experienced a 24-point improvement in their Kansas City Cardiomyopathy Questionnaire score. Credit: Jo Panuwat D / Shutterstock. Foldax has revealed one-year outcomes from the ...

Medtronic Diabetes has entered a partnership with professional tennis player Alexander Zverev to launch “Life Without Limits” – a global awareness campaign aimed at highlighting how diabetes ...

The platform aims to minimise the requirement of several clinicians during procedures, which is especially beneficial amidst nurse shortages. Credit: Robert Kneschke / Shutterstock. NanoVibronix has ...

Glaukos has secured EU Medical Device Regulation (EU-MDR) certification for its iStent infinite, along with other MIGS ...

Enterra Medical has commenced the randomised, multi-centre NAVIGATE study, designed to assess Gastric Electrical Stimulation ...

A professor from the University of Sheffield has received over £0.39m ($0.45m) in funding from Breast Cancer Now to develop a ...

Medical Research Council (MRC) has launched a new £50m ($68.6m) centre spread across collaborator sites in the UK to develop ...

The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.

Vivasure Medical has submitted an application seeking premarket approval from the FDA for its PerQseal Elite vascular closure ...